☰

Yongtao Li, Ph.D. - Publications

Affiliations: 
2003 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Biomedical Engineering
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Li YT, Kwon YM, Spangrude GJ, Liang JF, Chung HS, Park YJ, Yang VC. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy. Journal of Biomedical Materials Research. Part A. 91: 209-20. PMID 18814276 DOI: 10.1002/Jbm.A.32204  0.499
2008 Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. The ATTEMPTS delivery systems for macromolecular drugs. Expert Opinion On Drug Delivery. 5: 1255-66. PMID 18976135 DOI: 10.1517/17425240802498059  0.656
2008 Kwon YM, Li YT, Liang JF, Park YJ, Chang LC, Yang VC. PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 252-8. PMID 18652856 DOI: 10.1016/J.Jconrel.2008.06.017  0.634
2003 Park YJ, Liang JF, Song H, Li YT, Naik S, Yang VC. ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects. Advanced Drug Delivery Reviews. 55: 251-65. PMID 12564979 DOI: 10.1016/S0169-409X(02)00181-3  0.656
2002 Liang JF, Li YT, Song H, Park YJ, Naik SS, Yang VC. ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 78: 67-79. PMID 11772450 DOI: 10.1016/S0168-3659(01)00484-9  0.662
2001 Liang JF, Park YJ, Song H, Li YT, Yang VC. ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 72: 145-56. PMID 11389993 DOI: 10.1016/S0168-3659(01)00270-X  0.584
2000 Liang JF, Li YT, Connell ME, Yang VC. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system. Aaps Pharmsci. 2: E7. PMID 11741223 DOI: 10.1208/ps020107  0.534
2000 Liang JF, Li YT, Yang VC. A novel approach for delivery of enzyme drugs: preliminary demonstration of feasibility and utility in vitro. International Journal of Pharmaceutics. 202: 11-20. PMID 10915922 DOI: 10.1016/S0378-5173(00)00414-2  0.565
2000 Liang JF, Li YT, Yang VC. Biomedical application of immobilized enzymes. Journal of Pharmaceutical Sciences. 89: 979-90. PMID 10906721 DOI: 10.1002/1520-6017(200008)89:8<979::AID-JPS2>3.0.CO;2-H  0.444
2000 Liang JF, Song H, Li YT, Yang VC. A novel heparin/protamine-based pro-drug type delivery system for protease drugs. Journal of Pharmaceutical Sciences. 89: 664-73. PMID 10756332 DOI: 10.1002/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.0.CO;2-9  0.581
2000 Liang JF, Li Y, Yang VC. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation. Thrombosis Research. 97: 349-58. PMID 10709911 DOI: 10.1016/S0049-3848(99)00188-7  0.509
Show low-probability matches.